Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
Stanford researchers have developed an innovative, non-invasive therapeutic strategy to treat myocardial fibrosis (MF), a key driver of arrhythmia and heart failure in LMNA-related dilated cardiomyopathy (LMNA-DCM).
Stanford scientists have developed innovative methods for safely collecting, preserving, imaging, and molecularly profiling human brain tissue that remains on explanted intracranial electrodes used in neurosurgical procedures.
Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases, making it the leading cause of cancer-related deaths globally. Post-surgical recurrence and treatment resistance are the main causes of cancer-related mortality.
Stanford researchers have developed a neuromonitoring-guided cognitive intervention that enhances working memory by dynamically identifying and reinforcing engagement of individualized brain networks in real time.
The absence of a remote, reliable measure of rigidity, bradykinesia and tremor is a major limitation for telemedicine and multicenter clinical trials in Parkinson's disease (PD).
Researchers at Stanford University have demonstrated rapid and accurate identification of extracellular vesicles (EVs) from different cell lines using an AI-assisted optical platform.
Necrotizing enterocolitis is a life-threatening illness almost exclusively affecting the gastrointestinal tract of neonates. It's caused by bacterial invasion of the intestinal wall, which leads to inflammation and cellular destruction of the wall of the intestine.
Oral mucositis (OM) is a painful side effect of chemoradiotherapy, especially in children and adolescents, with a high incidence rate of over 20%-40% and up to 90% in high risk patients.
Stanford researchers have developed a mouth-cooling device that prevents or reduces the degree of oral mucositis (OM), a painful side effect of chemotherapy, radiotherapy, autoimmune conditions, and infections.
Stanford researchers have developed a novel CRISPR-based method, Oligo-LiveFISH, for generating large-scale pools of synthetic RNA oligos that enable multiplexed targeting, imaging, and manipulation of genomic regions in living cells.
The Stanford team developed a versatile injectable alginate-collagen hydrogel, a significant advancement in regenerative medicine and targeted therapeutic delivery.